Product Details for ANDA 209779
NITROGLYCERIN (NITROGLYCERIN)
0.3MG
Marketing Status: Prescription
0.4MG
Marketing Status: Prescription
0.6MG
Marketing Status: Prescription
0.3MG
Marketing Status: Prescription
Active Ingredient: NITROGLYCERIN
Proprietary Name: NITROGLYCERIN
Dosage Form; Route of Administration: TABLET; SUBLINGUAL
Strength: 0.3MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A209779
Product Number: 001
Approval Date: May 3, 2021
Applicant Holder Full Name: RUBICON RESEARCH PRIVATE LTD
Marketing Status: Prescription
Patent and Exclusivity Information
NITROGLYCERIN (NITROGLYCERIN)
Proprietary Name: NITROGLYCERIN
Dosage Form; Route of Administration: TABLET; SUBLINGUAL
Strength: 0.3MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A209779
Product Number: 001
Approval Date: May 3, 2021
Applicant Holder Full Name: RUBICON RESEARCH PRIVATE LTD
Marketing Status: Prescription
Patent and Exclusivity Information
0.4MG
Marketing Status: Prescription
Active Ingredient: NITROGLYCERIN
Proprietary Name: NITROGLYCERIN
Dosage Form; Route of Administration: TABLET; SUBLINGUAL
Strength: 0.4MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A209779
Product Number: 002
Approval Date: May 3, 2021
Applicant Holder Full Name: RUBICON RESEARCH PRIVATE LTD
Marketing Status: Prescription
Patent and Exclusivity Information
NITROGLYCERIN (NITROGLYCERIN)
Proprietary Name: NITROGLYCERIN
Dosage Form; Route of Administration: TABLET; SUBLINGUAL
Strength: 0.4MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A209779
Product Number: 002
Approval Date: May 3, 2021
Applicant Holder Full Name: RUBICON RESEARCH PRIVATE LTD
Marketing Status: Prescription
Patent and Exclusivity Information
0.6MG
Marketing Status: Prescription
Active Ingredient: NITROGLYCERIN
Proprietary Name: NITROGLYCERIN
Dosage Form; Route of Administration: TABLET; SUBLINGUAL
Strength: 0.6MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A209779
Product Number: 003
Approval Date: May 3, 2021
Applicant Holder Full Name: RUBICON RESEARCH PRIVATE LTD
Marketing Status: Prescription
Patent and Exclusivity Information
Proprietary Name: NITROGLYCERIN
Dosage Form; Route of Administration: TABLET; SUBLINGUAL
Strength: 0.6MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A209779
Product Number: 003
Approval Date: May 3, 2021
Applicant Holder Full Name: RUBICON RESEARCH PRIVATE LTD
Marketing Status: Prescription
Patent and Exclusivity Information